Cognitol Vinpocetine Tablet

COGNITOL

VINPOCETINE 5mg TABLET

Cognitol inhibits phosphodiesterase activity, prevents platelet aggregation and adenosine intake by erythrocytes.
It diminishes or suppresses disturbance due to hypoxia or deficient cerebral metabolism.

 

PHARMACOKINETICS

Cognitol is very well absorbed into intestines. Its bioavailability upon oral administration is about 57%, Vinpocetine 5 mg has half-life elimination after oral administration about 5 hours optimal concentration of active substance in plasma is 10 to 20ml.

 

INDICATION

Psychnic or neurological symptoms of cerebral circulatory disturbance of various origins (post apoplectic, post traumatic or sclerotic) such as impaired memory, locomotion disorder, vertigos and headaches. Intermittent cerebrovascular insufficiency, vascular spasms, ischemic cerebral lesions, advanced cerebral arteriosclerosis.

 

DOSAGE

1 tablet is to be taken 3 times per day. In prolonged treatment this dose must be maintained.

 

SIDE EFFECT

Slight decreases in blood pressure rarely tachycardia and extrasytole. Prolongs the excitability time of the ventricle (QT Time).

 

INDICATION LIMITS, CONTRAINDICATION

Pregnancy, lactation.

 

INTERACTIONS

According to experiments undertaken to date, tablets do not provoke interaction. They can therefore be administered together with other drugs.

 

STABILITY

3 Years.

 

NAFDAC Reg. No.: A4-1525

 

A pack contains 30 tablets of Cognitol (Vinpocetine 5mg)
Keep medicine out of reach children. By physician prescription only
Keep tightly closed and store in dry place below 25oC

 

Manufactured by

DIVINE ESSENTIAL FORMULATIONS
KM 10, LASU – Ojo Rd,

Igando, Lagos, Nigeria.

 

Distributed by

TYONEX NIG LTD

KM 10, LASU – Ojo Rd,

Igando, Lagos, Nigeria.